Medical Xpress·3 min read·medium
'Pro version' of cisplatin keeps its cancer-killing power while reducing side effects
K
Kajol, Rakesh Kumar Pathak
✦AI Summary
Researchers have developed 'cisproplatin,' a new molecule that combines the chemotherapy drug cisplatin with probenecid to reduce severe side effects. This 'pro version' remains stable in the body and only activates under tumor-like conditions, potentially protecting healthy organs.
edited by Lisa Lock , reviewed by Robert Egan
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in